期刊文献+

硝酸异山梨酯静脉泵入治疗高血压伴心力衰竭 被引量:4

Clinical Efficacy of Isosorbide Dinitrate Injection Infused by Syringe Pump in the Treatment of Hypertension with Heart Failure
下载PDF
导出
摘要 目的:研究硝酸异山梨酯直接静脉泵入治疗高血压心力衰竭的疗效及安全性。方法:将60例高血压伴心力衰竭患者随机分为①硝酸异山梨酯组30例和硝普钠组30例。通过输液泵直接静脉泵入硝酸异山梨酯20 mg(20 ml),②硝普钠组30例静脉滴注硝普钠25 mg+250ml 0.9%氯化钠注射液,两组均根据血压调整剂量。结果:硝酸异山梨酯组疗效略高于硝普钠组,但两组间总有效率比较差异无统计学意义(P>0.05)。硝酸异山梨酯组不良反应发生率11.63%,明显低于硝普钠组(P<0.05)。结论:硝酸异山梨酯原液直接经静脉泵入治疗高血压心力衰竭安全有效。 Objective: To evaluate the clinical efficacy of isosorbide dinitrate in the treatment of hypertension with cardiac failure. Method: 60 patients with hypertension with heart failure were randomly divided into isosorbide dinitrate group ( n = 30) infused 20 mg( 20 ml) with the aid of a syringe pump, or sodium nitrate group ( n = 30 ) 25 mg + 250 ml 0.9% sodium chloride injection by an intravenous injection. Result: The total effective rates were not statistically different between the two groups( P 〉 0.05 ). The side effects of the isosorbide dinitrate group were 11.63%, lower than those of the sodium nitrate group (P 〈 0.05). Conclusion: The efficacy of isosorbide dinitrate infused by a syringe pump in the treatment of hypertension with heart failure is effective and safe.
机构地区 解放军第
出处 《药物流行病学杂志》 CAS 2007年第3期140-142,共3页 Chinese Journal of Pharmacoepidemiology
关键词 硝酸异山梨酯 高血压 心力衰竭 Isosorbide dinitrate Hypertension Heart failure
  • 相关文献

参考文献4

二级参考文献21

  • 1施仲伟.高血压急症的诊断和治疗[J].内科急危重症杂志,2004,10(2):57-59. 被引量:19
  • 2王薇,赵冬,刘静,孙佳艺,吴桂贤,曾哲淳,刘军,秦兰萍,吴兆苏.中国35~64岁人群血压水平与10年心血管病发病危险的前瞻性研究[J].中华内科杂志,2004,43(10):730-734. 被引量:147
  • 3华琦,汤哲.北京市老年人群体重、血脂、血压及血糖水平的调查与分析[J].中华内科杂志,1997,36(1):18-20. 被引量:98
  • 4Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluatlon,and treatment of high blood pressure(the JNC 7 report)[J].JAMA,2003,289(19):2560-2572.
  • 5Guidelines Committee.2003 European society of hypertension-European society of cardiology guidelines for the management of arterial hypertension[J].J hypertension,2003,21(6):1011-1053.
  • 6Leopold G.Balanced pharmacokinetics and metabolism of bisoprolol[J].J Cardiovasc Pharmacol,1986,8(Suppl.11):S16-S20.
  • 7Ramsay LE,Yeo WW,Chadwick IG,et al.Diuretics.In:Swales JD,ed.Textbook of hypertension[M].Oxford:Blackwell Scientific Publications,1994.1046-1058.
  • 8Ruzicka M,Leenen FH.Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension[J].Drugs,2001,61(7):943-954.
  • 9Giesecke HG,Buchner MD.Three years of experience with bisoprolol in the treatment of mild to moderate hypertension[J].J Cardiovascpharmacol,1990,16(Suppl.5):S175-S178.
  • 10Frishman WH,Burris JF,Mroczek WJ,et al.First-line therapy option with low-dose bisoprolol fumarate and lowdose hydrochlorothiazide in patients with stage I and stage Ⅱ systemic hypertension[J].J Clin Pharmacol,1995,35(2):182-188.

共引文献175

同被引文献18

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部